| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |